Jones Financial Companies
IFRX icon

Jones Financial Companies’s InflaRx IFRX Stock Holding History

Jones Financial Companies’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42K Hold
1,784
– – ﹤0.01% 4258
2026
Q1 		$1.63K Hold
1,784
– – ﹤0.01% 4211
2025
Q4 		$1.8K Buy
+1,784
New +$2.22K ﹤0.01% 3848

Other funds holding IFRX

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Jones Financial Companies's IFRX Position: Q2 2026 in Review

Jones Financial Companies held its InflaRx (IFRX) position steady in Q2 2026 at 1,784 shares worth $3.42K. The position accounts for ﹤0.01% of the portfolio, ranked #4258.

Jones Financial Companies first reported a position in IFRX in Q4 2025 and has held it in 3 quarters since. 62 funds tracked by Wall St. Rank hold IFRX as of Q2 2026.

  • Jones Financial Companies held 1,784 shares of InflaRx worth $3.42K as of Q2 2026.
  • Jones Financial Companies left its InflaRx share count unchanged in Q2 2026.
  • InflaRx made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4258 holding.
  • Jones Financial Companies first reported a position in InflaRx in Q4 2025 and has held it in 3 quarters since.
  • 62 funds tracked by Wall St. Rank held InflaRx as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.